Digital health and rheumatology: The Indian context

IF 0.5 Q4 RHEUMATOLOGY Indian Journal of Rheumatology Pub Date : 2022-12-01 DOI:10.4103/injr.injr_127_21
Suchitra Kataria, V. Ravindran
{"title":"Digital health and rheumatology: The Indian context","authors":"Suchitra Kataria, V. Ravindran","doi":"10.4103/injr.injr_127_21","DOIUrl":null,"url":null,"abstract":"India as a country of contrast and diversity has witnessed digital evolution in different waves and stages. The technology is already an integral part of lives of millions in India; however, its application in the health management remains limited unlike developed economies. COVID-19 pandemic has plunged the country into universal, regional, or local lockdowns repeatedly since the last year. An unexpected and unforeseen impact of this has been the usage of technology for doctor–patient interactions through telemedicine. Hitherto limited to certain pockets, virtual interactions with doctors, ordering laboratory investigations through an application or procuring medicines through internet, are now part of mainstream patient behavior. This is a crucial change in the mindset but requires a lot more to be done at various levels to tap its full potential with rheumatologists being at the forefront and leading the change in their specialty. The pool of rheumatologists is very small and mostly concentrated in few urban areas, leading to diagnostic delay, suboptimal treatment, and poor outcomes. Technology could, therefore, become a catalyst for change and harbinger for greater clinician access. There are plenty of discussions about the impact and potential of deep learning, artificial intelligence, remote monitoring with wearables, etc., but plenty of them may not be relevant to Indian patients in the current scenario. Hence, the context, relevance, and applicability are the key for rheumatologists when making a judgment.","PeriodicalId":54167,"journal":{"name":"Indian Journal of Rheumatology","volume":"17 1","pages":"377 - 383"},"PeriodicalIF":0.5000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/injr.injr_127_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

India as a country of contrast and diversity has witnessed digital evolution in different waves and stages. The technology is already an integral part of lives of millions in India; however, its application in the health management remains limited unlike developed economies. COVID-19 pandemic has plunged the country into universal, regional, or local lockdowns repeatedly since the last year. An unexpected and unforeseen impact of this has been the usage of technology for doctor–patient interactions through telemedicine. Hitherto limited to certain pockets, virtual interactions with doctors, ordering laboratory investigations through an application or procuring medicines through internet, are now part of mainstream patient behavior. This is a crucial change in the mindset but requires a lot more to be done at various levels to tap its full potential with rheumatologists being at the forefront and leading the change in their specialty. The pool of rheumatologists is very small and mostly concentrated in few urban areas, leading to diagnostic delay, suboptimal treatment, and poor outcomes. Technology could, therefore, become a catalyst for change and harbinger for greater clinician access. There are plenty of discussions about the impact and potential of deep learning, artificial intelligence, remote monitoring with wearables, etc., but plenty of them may not be relevant to Indian patients in the current scenario. Hence, the context, relevance, and applicability are the key for rheumatologists when making a judgment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
数字健康和风湿病学:印度背景
印度作为一个充满反差和多样性的国家,经历了不同浪潮和阶段的数字化发展。这项技术已经成为印度数百万人生活中不可或缺的一部分;然而,与发达经济体不同,其在卫生管理中的应用仍然有限。自去年以来,新冠肺炎疫情使该国多次陷入普遍、地区或地方封锁。这带来了一个意想不到的影响,即通过远程医疗使用技术进行医患互动。迄今为止,与医生的虚拟互动,通过应用程序订购实验室检查或通过互联网购买药物,都局限于某些口袋,现在已成为主流患者行为的一部分。这是观念上的一个关键变化,但需要在各个层面上做更多的工作,以充分挖掘其潜力,风湿病学家站在最前沿,引领他们专业的变革。风湿病专家的数量非常少,而且主要集中在少数城市地区,导致诊断延误、治疗不理想和预后不佳。因此,技术可以成为变革的催化剂,并为更多的临床医生提供先兆。关于深度学习、人工智能、可穿戴设备远程监控等的影响和潜力,有很多讨论,但其中很多可能与当前情况下的印度患者无关。因此,风湿病学家在做出判断时,语境、相关性和适用性是关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.10
自引率
14.30%
发文量
73
审稿时长
13 weeks
期刊介绍: The Indian Journal of Rheumatology (IJR, formerly, Journal of Indian Rheumatology Association) is the official, peer-reviewed publication of the Indian Rheumatology Association. The Journal is published quarterly (March, June, September, December) by Elsevier, a division of Reed-Elsevier (India) Private Limited. It is indexed in Indmed and Embase. It is circulated to all bona fide members of IRA and subscribers.
期刊最新文献
Livedoid Vasculopathy: Successful Treatment with Tofacitinib Patient Research Partner as an Equal Member of the Research Team: A Personal Experience of the OMERACT Myositis Working Group Optimal health in rheumatology: The unmet need of the hour? Knowledge about rheumatoid arthritis among senior undergraduate medical students of a medical college in South India Safety and Efficacy of Golimumab in Rheumatoid Arthritis: A Prospective, Multicenter, Real-World Study from India
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1